FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma. - Wikidata - awgldk - TriplyDB

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

http://www.wikidata.org/entity/Q37404843

about

Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia.Ibrutinib and its use in the treatment of chronic lymphocytic leukemia.NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells.BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells.The potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia.Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer.The molecular pathogenesis of mantle cell lymphoma.

P2860

Q39325783-55AF7FFE-4487-4FA5-BC87-4A166D270720 Q47424531-91F430BC-B727-4845-9B6E-DF4395903950 Q47780043-71449996-A3B7-411B-A130-09CCB4792A44 Q49171204-309D5C95-BF5D-432E-B348-7F6C4040BDED Q50433449-201478FC-A6E3-4D59-A80F-CF2C05946986 Q51014811-2A71D224-2DF3-4266-90A4-2BDDA79F4059 Q54114538-733619C4-B5BC-4026-BB2A-FD4959820F04 Q55007581-2BE7A3B6-6879-4B4A-AE5A-A5AF766D248A

P2860

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

http://www.wikidata.org/entity/Q37404843

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

@en

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

@nl

type

label

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

@en

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

@nl

prefLabel

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

@en

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

@nl

P1433

Q37404843-D0F0B8C4-8BDD-48D5-BC39-6EE3D2FB6C2C

P1476

Q37404843-3CA57A18-C57A-4AB6-9C19-829119201B4C

P2093

Q37404843-059D8E0B-6A81-41CB-823B-A24155A7D944

Q37404843-15C6FFCC-C00C-4E6A-981E-B9F06B846C57

Q37404843-210A09C8-FDB1-4391-A0F9-3AC0851A4A44

Q37404843-2620E1A7-4DBC-4D4F-8474-E80E0468D902

Q37404843-4DCC36C3-FCBE-42A1-8B8B-0DC4DC1172EF

Q37404843-6DB175A3-35A1-4E35-B065-EB67AB8FAA4D

Q37404843-76ED75A8-A46C-47DC-B3D9-6B312EB832AB

Q37404843-806EEC57-69FF-4575-9B95-6A99875310CB

Q37404843-81628C46-4804-49CD-BB8F-565C5B734188

Q37404843-93CA5798-C8E6-4CD5-847C-FEDA4D0E7911

P2860

Q37404843-06130800-C08F-433E-9E52-CF733857259D

Q37404843-0CBD372A-4D05-45EE-9880-3BEF7696E165

Q37404843-13361BDC-5BC7-4ACC-8FB8-C825BC82DDAF

Q37404843-1CD4FFD0-4390-4613-85E2-BE5A41D2957F

Q37404843-204D66C4-A300-4B69-92E2-EDBD93C47CBA

Q37404843-20ECCCF7-1F40-4FB9-9EDE-6206BDBCCC22

Q37404843-2A069A33-E49E-4348-9E46-D604F5293796

Q37404843-2AE25E16-A2E5-4974-8D0B-F3A1E28CBD01

Q37404843-2C467F24-A407-413E-B494-28F80E5C5D68

Q37404843-2E75D2F5-C260-4B3C-B4E7-13922EDCA65D

P2888

Q37404843-18147A18-89A7-4061-9DEA-8093EE510DE9

P304

Q37404843-A2651BA4-2CA6-4ADB-A13E-13A884845D33

P31

Q37404843-A5CCA26B-306A-431C-BD50-2AAF882A0C16

P356

Q37404843-59D37E9F-2951-4AE0-9A6A-4FC168EF8374

P407

Q37404843-11A64D9F-EF09-4ABF-B4FB-03E0D3DE619A

P433

Q37404843-57F8F702-D6BA-4D72-8FE7-A7669807E900

P478

Q37404843-8E3E03DE-A3EA-4CD8-AC4D-7C13F97328D6

P50

Q37404843-7D7C038D-676A-49E0-898E-CCB45F43DFA3

Q37404843-FE47B229-160D-4D01-A77C-6BEBE282269A

P577

Q37404843-6C26A7A6-9139-4108-92E5-9C0D652D1504

P698

Q37404843-3A35613E-8A25-4556-B115-DF393FB7BAD8

P921

Q37404843-B4BEEF81-7C42-4DDA-97DF-85902DCD6747

P932

Q37404843-3C64E45D-27EF-4E35-B9D8-555E23D2C7FF

P356

P1433

P1476

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma

@en

P2093

B S Kahl

http://www.w3.org/2001/XMLSchema#string

C J Thomas

http://www.w3.org/2001/XMLSchema#string

D T Yang

http://www.w3.org/2001/XMLSchema#string

J C Eickhoff

http://www.w3.org/2001/XMLSchema#string

J Wolff

http://www.w3.org/2001/XMLSchema#string

K M Grindle

http://www.w3.org/2001/XMLSchema#string

L Lu

http://www.w3.org/2001/XMLSchema#string

L Rui

http://www.w3.org/2001/XMLSchema#string

N Pflum

http://www.w3.org/2001/XMLSchema#string

P Jobin

http://www.w3.org/2001/XMLSchema#string

P2860

Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

Follicular lymphoma: 2014 update on diagnosis and management

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas

Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

AP-1: a double-edged sword in tumorigenesis

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

P2888

P304

6223-6234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2016.155

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Christian M. Capitini

Myriam N Bouchlaka

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27157620

http://www.w3.org/2001/XMLSchema#string

P921

P932

5102814

http://www.w3.org/2001/XMLSchema#string